Go Pro

Insider Selling: Synopsys (NASDAQ:SNPS) Insider Sells $11,138,750.00 in Stock

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Synopsys insider Geus Aart De sold 25,000 shares for approximately $11.14 million at an average price of $445.55. The sale, conducted under a pre-arranged Rule 10b5-1 plan, reduced his direct ownership by 17.19% to 120,421 shares.
  • Synopsys reported quarterly adjusted earnings of $3.91 per share and revenue of $2.48 billion, exceeding estimates; revenue increased 42.4% year over year.
  • Analyst sentiment remains broadly positive, with 12 Buy, five Hold, and one Sell rating and an average price target of $561.28, despite shares trading down 0.7% to $439.59.
  • Five stocks to consider instead of Synopsys.

Synopsys, Inc. (NASDAQ:SNPS - Get Free Report) insider Geus Aart De sold 25,000 shares of the stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $445.55, for a total transaction of $11,138,750.00. Following the completion of the sale, the insider directly owned 120,421 shares in the company, valued at $53,653,576.55. This trade represents a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Synopsys Trading Down 0.7%

Shares of NASDAQ:SNPS traded down $3.02 during trading hours on Monday, hitting $439.59. 1,680,894 shares of the company's stock traded hands, compared to its average volume of 1,998,091. The firm has a market capitalization of $84.24 billion, a P/E ratio of 77.67, a price-to-earnings-growth ratio of 2.42 and a beta of 1.23. The business has a fifty day moving average price of $416.64 and a 200-day moving average price of $440.14. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $615.79. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The firm had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. During the same period in the prior year, the business posted $3.39 earnings per share. The company's revenue for the quarter was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities analysts expect that Synopsys, Inc. will post 11.03 earnings per share for the current year.

Institutional Trading of Synopsys

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Synopsys during the 2nd quarter worth approximately $747,400,000. Norges Bank acquired a new stake in Synopsys in the fourth quarter valued at $730,197,000. Man Group plc purchased a new position in shares of Synopsys in the second quarter valued at $55,900,000. SBI Okasan Asset Management Co.Ltd. acquired a new position in shares of Synopsys during the 4th quarter worth $1,699,000. Finally, Czech National Bank boosted its position in shares of Synopsys by 4.6% in the 2nd quarter. Czech National Bank now owns 54,526 shares of the semiconductor company's stock worth $24,322,000 after buying an additional 2,421 shares in the last quarter. Institutional investors own 85.47% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. BNP Paribas Exane upped their target price on shares of Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a research note on Thursday, May 28th. Piper Sandler raised shares of Synopsys from a "neutral" rating to an "overweight" rating and lifted their price target for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. KeyCorp reiterated an "overweight" rating on shares of Synopsys in a report on Wednesday, August 19th. Morgan Stanley reduced their price objective on Synopsys from $525.00 to $500.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 19th. Finally, Berenberg Bank set a $633.00 target price on Synopsys in a research report on Wednesday, May 27th. Twelve analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Synopsys has an average rating of "Moderate Buy" and an average target price of $561.28.

Read Our Latest Research Report on Synopsys

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Insider Buying and Selling by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines